Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Michael Spigarelli Insider Profile
4 Followers
Michael Spigarelli, Chief Medical Officer at PsyBio Therapeutics, holds 2.13M shares in PsyBio Therapeutics (Ticker: TSE:PSYB.H). Most recently, Michael Spigarelli Bought C$2,134,062 shares of PsyBio Therapeutics on Jan 16, 2023 for an estimated value of 106.70K.
Michael Spigarelli has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Michael Spigarelli's holdings
Insider Roles
Chief Medical Officer
Roles that Michael Spigarelli holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Michael Spigarelli
Michael Spigarelli's Trading History
List of latest transactions for each holding click on a transaction to see Michael Spigarelli's performance on stock
You May Also Like
Michael Spigarelli insider profile FAQ
What is the percentage of profitable transactions made by Michael Spigarelli?
The percentage of profitable transactions made by Michael Spigarelli is ―.
What is the average return per transaction made by Michael Spigarelli?
The average return per transaction made by Michael Spigarelli is ―.
What stocks does Michael Spigarelli hold?
Michael Spigarelli holds: TSE:PSYB.H stocks.
What was Michael Spigarelli’s latest transaction?
Michael Spigarelli latest transaction was an Informative Buy of C$106.70K.
What was Michael Spigarelli's most profitable transaction?
Michael Spigarelli’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Michael Spigarelli's role in PsyBio Therapeutics?
Michael Spigarelli's role in PsyBio Therapeutics is Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.